Inhibitor Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 12, 2020 at 09:03 am
Inhibitor Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating loss was USD 315,044 compared to USD 635,500 a year ago. Net loss was USD 314,894 compared to USD 632,691 a year ago. For the half year, operating loss was USD 700,486 compared to USD 1.427 million a year ago. Net loss was USD 699,311 compared to USD 1.418 million a year ago.